Cite

    Hayman, J. et al. (2018). Detectable end of radiation prostate specific antigen assists in identifying men with unfavorable intermediate‐risk prostate cancer at high risk of distant recurrence and cancer‐specific mortality. Prostate. 78 (8), pp. 623-630. [Online].